These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20108381)

  • 21. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.
    Menteş BB; Irkörücü O; Akin M; Leventoğlu S; Tatlicioğlu E
    Dis Colon Rectum; 2003 Feb; 46(2):232-7. PubMed ID: 12576897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pain induced by injection of hypertonic saline into the infrapatellar fat pad and effect on coordination of the quadriceps muscles.
    Hodges PW; Mellor R; Crossley K; Bennell K
    Arthritis Rheum; 2009 Jan; 61(1):70-7. PubMed ID: 19116977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin injection to facilitate rehabilitation of muscle imbalance syndromes in sports medicine.
    Cullen DM; Boyle JJ; Silbert PL; Singer BJ; Singer KP
    Disabil Rehabil; 2007 Dec; 29(23):1832-9. PubMed ID: 18033608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin A for the treatment of chronic anal fissure.
    Brisinda G; Cadeddu F; Mazzeo P; Maria G
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):219-28. PubMed ID: 19072412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin. The Newport Beach experience.
    Fulton JE
    Dermatol Surg; 1998 Nov; 24(11):1219-24. PubMed ID: 9834742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA; Buwalda J
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M; Wissel J
    Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-plane injection of botulinum exotoxin A in glabellar frown lines.
    Ozsoy Z; Gözü A; Genç B
    Aesthetic Plast Surg; 2004; 28(2):114-5. PubMed ID: 15170246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A.
    Kranz G; Sycha T; Voller B; Kranz GS; Schnider P; Auff E
    Neurology; 2008 Jan; 70(2):133-6. PubMed ID: 18180443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox).
    Fortuna R; Vaz MA; Youssef AR; Longino D; Herzog W
    J Biomech; 2011 Jan; 44(1):39-44. PubMed ID: 20828699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Split-screen video demonstration of sonography-guided muscle identification and injection of botulinum toxin.
    Fietzek UM; Schroeder AS; Wissel J; Heinen F; Berweck S
    Mov Disord; 2010 Oct; 25(13):2225-8. PubMed ID: 20721881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical denervation with botulinum neurotoxin a improves the surgical manipulation of the muscle-tendon unit: an experimental study in an animal model.
    Mannava S; Callahan MF; Trach SM; Wiggins WF; Smith BP; Koman LA; Smith TL; Tuohy CJ
    J Hand Surg Am; 2011 Feb; 36(2):222-31. PubMed ID: 21276885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.
    Minamoto VB; Suzuki KP; Bremner SN; Lieber RL; Ward SR
    Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee Pain.
    Singer BJ; Silbert BI; Silbert PL; Singer KP
    Toxins (Basel); 2015 Aug; 7(9):3388-404. PubMed ID: 26308056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining ultrasonography and electromyography for botulinum chemodenervation treatment of thoracic outlet syndrome: comparison with fluoroscopy and electromyography guidance.
    Jordan SE; Ahn SS; Gelabert HA
    Pain Physician; 2007 Jul; 10(4):541-6. PubMed ID: 17660852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NeuroBloc/Myobloc: unique features and findings.
    Arezzo JC
    Toxicon; 2009 Oct; 54(5):690-6. PubMed ID: 19286001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.